ALKERMES | 판매 및 관리 비용

Selling And Administration Expenses 변화 날짜
AbbVie USD 3.61B 273M 2023-12
Acadia Pharmaceuticals USD 111.46M 13.58M 2023-12
ALKERMES USD 167.95M 37.31M 2023-09
Amgen USD 1.76B 424M 2023-12
Biogen USD 608.5M 179.7M 2023-12
BioMarin Pharmaceutical USD 275.02M 51.1M 2023-12
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Eli Lilly USD 1.92B 120.7M 2023-12
Gilead Sciences USD 1.61B 293M 2023-12
Intra Cellular Therapies USD 104.72M 487K 2023-12
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
Malin Corporation EUR 2.2M 800K 2023-06
Merck USD 2.75B 272M 2023-12
Neurocrine Biosciences USD 204.2M 17.6M 2023-09
Otsuka Holdings JPY 204.45B 7.72B 2023-09
Pfizer USD 4.47B 1.27B 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09



ALKERMES 판매 및 관리 비용 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Apr 2024.